Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Wagner

Showing results (301-310 of 355) with videos related to

Pageof 36
Sort By:
JAMA Network Open|July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In SituVictoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2022
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease RegistryHans C Lee, Karthik Ramasamy, Katja Weisel, et al.
Tumori|June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissectionU Veronesi, J Adamus, D C Bandiera, et al.
Cancer|June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremitiesU Veronesi, J Adamus, D C Bandiera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO GuidelineJun J Mao, Nofisat Ismaila, Ting Bao, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609Laurie E McLouth, Yue Zheng, Stephanie Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)Seema A Khan, Fengmin Zhao, Lori J Goldstein, et al.
Cardio-Oncology (London, England)|June 6, 2024
The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancerLeila Mabudian, Kerry Reding, Ralph B D'Agostino, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 28, 2010
NCCN Clinical Practice Guidelines Cancer-related fatigueAnn M Berger, Amy Pickar Abernethy, Ashley Atkinson, et al.
Pageof 36

Showing results (301-310 of 355) with videos related to

Sort By:
Pageof 36
JAMA Network Open|July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In SituVictoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2022
Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease RegistryHans C Lee, Karthik Ramasamy, Katja Weisel, et al.
Tumori|June 30, 1980
Stage I melanoma of the limbs. Immediate versus delayed node dissectionU Veronesi, J Adamus, D C Bandiera, et al.
Cancer|June 1, 1982
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremitiesU Veronesi, J Adamus, D C Bandiera, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2022
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO GuidelineJun J Mao, Nofisat Ismaila, Ting Bao, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2022
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609Laurie E McLouth, Yue Zheng, Stephanie Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2024
Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810Leonard J Appleman, Se Eun Kim, Wayne B Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2022
Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (EA2108)Seema A Khan, Fengmin Zhao, Lori J Goldstein, et al.
Cardio-Oncology (London, England)|June 6, 2024
The relationship between body composition and left ventricular performance in women with breast, lymphoma, or sarcoma cancerLeila Mabudian, Kerry Reding, Ralph B D'Agostino, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 28, 2010
NCCN Clinical Practice Guidelines Cancer-related fatigueAnn M Berger, Amy Pickar Abernethy, Ashley Atkinson, et al.
Pageof 36